Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $26.60M.
ENTERPRISE VALUE (EV)
$26.60M
PAVmed Inc.
Market Cap
$17.04M
Enterprise Value (EV)
$26.60M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| PAVmed Inc. (PAVM) | $17.04M | $26.60M |
| Lipocine Inc. (LPCN)vs › | $17.15M | $12.17M |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.17M | $5.84M |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | $9.49M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.74M | $19.72M |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.67M | $7.40M |
| Cosmos Health Inc. (COSM)vs › | $17.50M | $31.68M |
| Dyadic International, Inc. (DYAI)vs › | $16.55M | $20.17M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.87M | $17.73M |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.84M | $176.75M |
Market Cap
$17.04M
Total Debt
$11.10M
Cash
$1.54M
Enterprise Value
$26.60M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
